近年来,国内创新药出海潮涌现,同时中国药企出海模式正从单一产品授权向多元化战略合作升级,其中,NewCo模式屡见不鲜。NewCo模式是指通过成立新的公司(NewCo),将特定的资产(如药物研发管线)作为核心,吸引外部投资者融资,并推动资产进一步开发和商业化。相较于传统 BD 模式,NewCo 模式在合作结构、所有权分配、财务灵活性以及品牌和市场进入等方面,展现出诸多优势。业内表示,这一转变既得益于...
Source Link近年来,国内创新药出海潮涌现,同时中国药企出海模式正从单一产品授权向多元化战略合作升级,其中,NewCo模式屡见不鲜。NewCo模式是指通过成立新的公司(NewCo),将特定的资产(如药物研发管线)作为核心,吸引外部投资者融资,并推动资产进一步开发和商业化。相较于传统 BD 模式,NewCo 模式在合作结构、所有权分配、财务灵活性以及品牌和市场进入等方面,展现出诸多优势。业内表示,这一转变既得益于...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.